Cargando…
Cytomegalovirus viraemia and mortality in renal transplant recipients in the era of antiviral prophylaxis. Lessons from the western Australian experience
BACKGROUND: Cytomegalovirus (CMV) establishes a lifelong infection that is efficiently controlled by the immune system; this infection can be reactivated in case of immunosuppression such as following solid organ transplantation. CMV viraemia has been associated with CMV disease, as well as increase...
Autores principales: | Selvey, Linda A., Lim, Wai H., Boan, Peter, Swaminathan, Ramyasuda, Slimings, Claudia, Harrison, Amy E., Chakera, Aron |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514475/ https://www.ncbi.nlm.nih.gov/pubmed/28716027 http://dx.doi.org/10.1186/s12879-017-2599-y |
Ejemplares similares
-
JC viraemia in kidney transplant recipients: to act or not to act?
por: Rao, N., et al.
Publicado: (2012) -
The Association Between Cytomegalovirus Infection and Cardiac Allograft Vasculopathy in the Era of Antiviral Valganciclovir Prophylaxis
por: Klimczak-Tomaniak, Dominika, et al.
Publicado: (2019) -
Evaluation on the antiviral activity of arctigenin against spring viraemia of carp virus
por: Shen, Yu-Feng, et al.
Publicado: (2018) -
Antiviral prophylaxis inhibits cytomegalovirus reactivation in critical illness
por: Cowley, NJ, et al.
Publicado: (2015) -
1109. Valgancyclovir Dosing for Cytomegalovirus Prophylaxis in Heart Transplant Recipients
por: Huang, Glen, et al.
Publicado: (2020)